课题基金 / 基金详情

Project 1

Project 1
项目1
批准号:
10411221
负责人:
KARLA M KERLIKOWSKE
金额:
$14.95万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-09-27 至 2027-05-31

项目摘要

项目成果

KARLA M KERLIKOWSKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – Project 1 Screening mammography results in lower breast cancer mortality by reducing the incidence of advanced breast cancer. Advanced cancer occurs in about 22% of routinely screened women diagnosed with breast cancer, with advanced cancer rates more than 2-fold higher in Black vs. White women. We have identified advanced cancer rate as a key screening outcome because it best discriminates who has the highest risk of breast cancer death. Identifying women at increased advanced cancer risk and targeting them with effective screening strategies could reduce breast cancer mortality. Thus, Project 1 aims to advance a new risk-based screening paradigm that identifies women’s absolute advanced cancer risk to inform screening intensity and supplemental imaging decisions. Aim 1) Using Breast Cancer Surveillance Consortium data on screening exams from women aged 40-74 years, and advanced breast cancers, we will develop, evaluate, and validate new risk prediction models to identify women at high risk of advanced breast cancer. We will combine clinical breast cancer risk factors, self-reported race/ethnicity, imaging features, and Artificial Intelligence output to estimate cumulative 6-year advanced cancer risk using novel discrete time survival models incorporating modern data-adaptive modeling approaches for annual and biennial screeners and examine model predictive equity by race/ethnicity. Aim 2) We will statistically emulate a randomized trial within a causal inference framework to evaluate annual vs. biennial mammography screening on breast cancer mortality among the general screening population according to advanced cancer risk. Aim 3) Three established breast cancer simulation models will be used to evaluate the long-term benefits (breast cancer deaths averted, and life years gained) and harms (e.g., false positives and biopsies) of population-level screening strategies that target mammography frequency (annual, biennial) and supplemental MRI based on advanced cancer risk. This proposal will answer: 1) Which women undergoing screening mammography are at high risk of advanced cancer and require an alternative strategy to biennial mammography, and which women are at low risk and can be screened less often? 2) What advanced cancer risk levels require annual mammography vs. biennial mammography for similar reductions in breast cancer mortality? 3) Does a risk-based screening strategy using advanced cancer risk to inform screening frequency and modality improve outcomes compared to an agebased strategy? Therefore, this project will provide evidence to guide women and providers towards equitable screening strategies based on advanced cancer risk to maximize screening benefits while minimizing harms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hawaii Pacific Islands Mammography Registry
  • 批准号:
    10819068
  • 项目类别:
  • 资助金额:
    $5.55万
  • 财政年份:
    2023
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
Hawaii Pacific Islands Mammography Registry
  • 批准号:
    10588112
  • 项目类别:
  • 资助金额:
    $68.89万
  • 财政年份:
    2023
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
Evaluation of novel tomosynthesis density measures in breast cancer risk prediction
  • 批准号:
    10680241
  • 项目类别:
  • 资助金额:
    $70.18万
  • 财政年份:
    2023
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
New Risk Assessment Paradigm to Predict Screening Detection, Failures and False Alarms
  • 批准号:
    9982825
  • 项目类别:
  • 资助金额:
    $27.72万
  • 财政年份:
    2020
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: